Macrogenics Inc (MGNX)
3.65
-0.16
(-4.20%)
USD |
NASDAQ |
Nov 15, 10:02
Macrogenics Cash and Short Term Investments (Quarterly): 200.36M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 200.36M |
| June 30, 2024 | 140.37M |
| March 31, 2024 | 184.24M |
| December 31, 2023 | 229.80M |
| September 30, 2023 | 256.43M |
| June 30, 2023 | 240.35M |
| March 31, 2023 | 241.66M |
| December 31, 2022 | 154.35M |
| September 30, 2022 | 123.62M |
| June 30, 2022 | 133.74M |
| March 31, 2022 | 183.99M |
| December 31, 2021 | 243.62M |
| September 30, 2021 | 298.90M |
| June 30, 2021 | 297.32M |
| March 31, 2021 | 343.18M |
| December 31, 2020 | 272.53M |
| September 30, 2020 | 280.66M |
| June 30, 2020 | 232.80M |
| March 31, 2020 | 170.85M |
| December 31, 2019 | 215.76M |
| September 30, 2019 | 254.42M |
| June 30, 2019 | 272.14M |
| March 31, 2019 | 320.39M |
| December 31, 2018 | 232.86M |
| Date | Value |
|---|---|
| September 30, 2018 | 260.14M |
| June 30, 2018 | 300.89M |
| March 31, 2018 | 260.08M |
| December 31, 2017 | 305.12M |
| September 30, 2017 | 203.65M |
| June 30, 2017 | 243.66M |
| March 31, 2017 | 243.10M |
| December 31, 2016 | 277.00M |
| September 30, 2016 | 311.12M |
| June 30, 2016 | 265.62M |
| March 31, 2016 | 304.45M |
| December 31, 2015 | 339.05M |
| September 30, 2015 | 365.77M |
| June 30, 2015 | 235.03M |
| March 31, 2015 | 263.13M |
| December 31, 2014 | 157.59M |
| September 30, 2014 | 179.19M |
| June 30, 2014 | 194.01M |
| March 31, 2014 | 198.72M |
| December 31, 2013 | 116.48M |
| September 30, 2013 | 33.57M |
| June 30, 2013 | 33.78M |
| December 31, 2012 | 47.74M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
123.62M
Minimum
Sep 2022
343.18M
Maximum
Mar 2021
222.23M
Average
231.30M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| KORU Medical Systems Inc | 10.46M |
| Apellis Pharmaceuticals Inc | 396.86M |
| NovaBay Pharmaceuticals Inc | 0.776M |
| Palatin Technologies Inc | 9.527M |
| iBio Inc | 14.21M |